Less than a decade ago, in 2010, over 130 million prescriptions for APAP/hydrocodone were filled in the United States.3 Reportedly, 63% of unintentional overdoses of APAP occur with use of the opioid/APAP combination, with an additional 17% of adults suffering liver injury.5,6 Fortunately, the United States FDA has recognized the dangers of the prescription combination of APAP and narcotic analgesics and, in January 14, 2014, implemented a fixed amount of APAP approved per dosage unit of combination analgesics tablets in effective practice
Serial national surveys conducted in the United States indicated a rise in MAFLD prevalence from 28.4% during the period of 19992002 to 35.8% during the period of 20112016 (13)
The same survey reported that about 60% of GLP-1 users reported drinking less alcohol since beginning treatment, with 14-18% quitting drinking completely
Because the compounds are formulated together in precise proportions, patients avoid the unpredictability of timing two separate medications